Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density

NCT01406548 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteopenia
Osteoporosis

Interventions

DRUG: BPS804 20mg/Kg
DRUG: Placebo to 20mg/Kg BPS804

Sponsor

Ultragenyx Pharmaceutical Inc

Collaborators

[object Object]
[object Object]